Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

ACMBernstein SICAV - International Health Care Portfolio

+ Add to Watchlist

ACMHCII:LX

308.56 USD 0.97 0.31%

As of 00:59:30 ET on 04/24/2015.

Snapshot for ACMBernstein SICAV - International Health Care Portfolio (ACMHCII)

Year To Date: +12.65% 3-Month: +8.44% 3-Year: +22.19% 52-Week Range: 243.57 - 310.01
1-Month: -0.07% 1-Year: +26.87% 5-Year: +15.16% Beta vs MXWO0HC: 1.00

Mutual Fund Chart for ACMHCII

No chart data available.
  • ACMHCII:LX 308.56
  • 1M
  • 1Y
Interactive ACMHCII Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ACMHCII

AllianceBernstein - International Health Care Portfolio is an open-end fund incorporated in Luxembourg. The Portfolio's objective is growth of capital. The Investment Manager expects that at any time at least 80% of the Portfolio's total assets will be invested in securities issued by companies principally engaged in health care and health care-related industries.

Inception Date: 02-17-1999 Telephone: -
Managers: JOHN FOGARTY / VINAY THAPAR
Web Site: www.abglobal.com

Fundamentals for ACMHCII

NAV (on 2015-04-24) 308.56
Assets (M) (on 2015-04-24) 483.70
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment -

Dividends for ACMHCII

No dividends reported

Fees & Expenses for ACMHCII

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.51

Top Fund Holdings for ACMHCII

Filing Date: 02/28/2015
Name Position Value % of Total
Pfizer Inc 965,790 33,145,913 8.022%
Roche Holding AG 109,582 29,859,946 7.226%
GlaxoSmithKline PLC 1,126,360 26,707,508 6.463%
Novartis AG 234,920 24,026,232 5.814%
Gilead Sciences Inc 214,775 22,235,656 5.381%
Anthem Inc 126,760 18,598,227 4.501%
Medtronic PLC 226,167 17,548,298 4.247%
Johnson & Johnson 155,480 15,938,255 3.857%
Biogen Inc 31,330 12,832,455 3.106%
Allergan Inc/United States 53,992 12,566,098 3.041%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil